Medicare Advantage fight shifts to 340B arena

04/24/24 at 03:00 AM

Medicare Advantage fight shifts to 340B arena 
Modern Healthcare; by Alex Kacik; 4/22/24
Hospitals' fight to boost Medicare Advantage reimbursement has extended to plans' pay for 340B drugs. The hospitals’ plea to adjust Medicare Advantage pay stems from regulation aimed at making providers that participate in the drug discount program whole after the Supreme Court reversed 340B rate cuts that were in place from 2018 to 2022.

Back to Literature Review